Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for Alere Toxicology Services, Inc.�
39.80
Nov 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 31.94 - 43.00
Open     -
Vol / Avg. 0.00/522,363.00
Mkt cap 3.33B
P/E     -
Div/yield     -
EPS -2.04
Shares 83.56M
Beta 1.93
Inst. own 94%
Feb 4, 2015
Q4 2014 Alere Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 20, 2014
Alere Inc at Jefferies Global Healthcare Conference - London
Oct 28, 2014
Q3 2014 Alere Inc Earnings Release
Oct 28, 2014
Q3 2014 Alere Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -13.55% -2.90%
Operating margin 5.09% 4.44%
EBITD margin - 20.13%
Return on average assets -5.80% -1.24%
Return on average equity -28.87% -6.08%
Employees 17,600 -
CDP Score - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�s segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Officers and directors

Namal Nawana President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Daniella Cramp Global President - cardiometabolic business unit
Age: 40
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President - Alere International Limited
Age: 50
Bio & Compensation  - Reuters
Craig Keyes M.D. Global President - Alere Health Information Solutions
Age: 58
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 44
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 65
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 67
Bio & Compensation  - Reuters
Carla Flakne Chief Accounting Officer, Vice President
Age: 60
Bio & Compensation  - Reuters